Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 25 Oct 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.